Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, end points/outcomes of interest, statistical analysis plan, data requirements, publication plan and qualifications of the researcher(s)
Emerging human data, including small pilot studies showing good tolerability (e.g., intravenous infusions up to 20 mg with no adverse effects) and subjective improvements in conditions like chronic knee pain, further support its promise
Cipto Mangunkusumo Hospital in Jakarta, Indonesia
8,00025,000 per session Oral Liquid: Rs
Our medical team can help you understand the compliance considerations for your specific situation